๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinicopathological features of lung adenocarcinoma with KRAS mutations

โœ Scribed by Seiichi Kakegawa; Kimihiro Shimizu; Masayuki Sugano; Yohei Miyamae; Kyoichi Kaira; Takuya Araki; Tetsuhiro Nakano; Mitsuhiro Kamiyoshihara; Osamu Kawashima; Izumi Takeyoshi

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
350 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prognostic value of loss of heterozygosi
Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma
โœ Laura De Gregorio; Giacomo Manenti; Matteo Incarbone; Silvana Pilotti; Ugo Pasto ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 89 KB

The prognostic values of loss of heterozygosity (LOH) at loci frequently involved in non-small cell lung cancer and of KRAS2 gene mutations were studied in lung adenocarcinoma patients. LOHs were relatively common, ranging from 24% at chromosome 10p to 55% at chromosome 17p13. KRAS2 mutations at cod

Analysis of loss of heterozygosity and K
Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations
โœ Georgia Chenevix-Trench; Judith Kerr; Terry Hurst; Yang-Chia Shih; David Purdie; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB

The molecular events that give rise to ovarian epithelial neoplasms are not well understood. In particular, it is not known whether adenocarcinomas arise from benign or low malignant potential (LMP) precursors. We have examined a large series of benign (25) and LMP (31) ovarian tumors for loss of he